Otezla (apremilast)

pCPA File Number: 21208
Negotiation Status:
Concluded without agreement
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: